Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | ACAD9 CL E G H | 28976 | 611126 | Acyl-CoA dehydrogenase family, member 9, deficiency of | 611126 | C1970173 | OMIM | 1 | | 771 | 21497 | 611103 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | ACTA1 CL E G H | 58 | 171439 | | | | ORPHA | 1 | | 506 | 129 | 102610 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | AGK CL E G H | 55750 | 212350 | Cataract and cardiomyopathy | 212350 | C1859317 | OMIM | 1 | | 347 | 21869 | 610345 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | APOPT1 CL E G H | 84334 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 197 | 20492 | 616003 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | ATP5F1D CL E G H | 513 | 618120 | MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5 | 618120 | CN253835 | OMIM | 1 | | 122 | 837 | 603150 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | BCS1L CL E G H | 617 | 124000 | Mitochondrial complex III deficiency | 124000 | C1852372 | OMIM | 1 | | 413 | 1020 | 603647 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | C1QBP CL E G H | 708 | 617713 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 | 617713 | C4540209 | OMIM | 1 | | 137 | 1243 | 601269 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | CAVIN1 CL E G H | 284119 | 613327 | Lipodystrophy, congenital generalized, type 4 | 613327 | C2750069 | OMIM | 1 | | 128 | 9688 | 603198 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | CHCHD10 CL E G H | 400916 | 457050 | | | | ORPHA | 1 | | 297 | 15559 | 615903 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | CHCHD10 CL E G H | 400916 | 616209 | Myopathy, isolated mitochondrial, autosomal dominant | 616209 | C4015513 | OMIM | 1 | | 297 | 15559 | 615903 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COA7 CL E G H | 65260 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 58 | 25716 | 615623 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COL13A1 CL E G H | 1305 | 616720 | Myasthenic syndrome, congenital, 19 | 616720 | C4225235 | OMIM | 1 | | 559 | 2190 | 120350 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COQ8A CL E G H | 56997 | 139485 | | | | ORPHA | 1 | | 699 | 16812 | 606980 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COQ8A CL E G H | 56997 | 612016 | Coenzyme Q10 deficiency, primary, 4 | 612016 | C2677589 | OMIM | 1 | | 699 | 16812 | 606980 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COX10 CL E G H | 1352 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 356 | 2260 | 602125 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COX14 CL E G H | 84987 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 38 | 28216 | 614478 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COX20 CL E G H | 116228 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 206 | 26970 | 614698 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COX6B1 CL E G H | 1340 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 68 | 2280 | 124089 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | COX8A CL E G H | 1351 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 32 | 2294 | 123870 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | DMD CL E G H | 1756 | 98895 | | | | ORPHA | 1 | | 8184 | 2928 | 300377 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | DNA2 CL E G H | 1763 | 615156 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6 | 615156 | C3554599 | OMIM | 1 | | 601 | 2939 | 601810 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | ENO3 CL E G H | 2027 | 612932 | Glycogen storage disease type 13 | 612932 | C2752027 | OMIM | 1 | | 317 | 3354 | 131370 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | FASTKD2 CL E G H | 22868 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 401 | 29160 | 612322 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | FLAD1 CL E G H | 80308 | 255100 | Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency | 255100 | C4310822 | OMIM | 1 | | 235 | 24671 | 610595 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | GMPPB CL E G H | 29925 | 615352 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14 | 615352 | C3714932 | OMIM | 1 | | 364 | 22932 | 615320 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | GYS1 CL E G H | 2997 | 611556 | Glycogen storage disease 0, muscle | 611556 | C1969054 | OMIM | 1 | | 607 | 4706 | 138570 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | HADHA CL E G H | 3030 | 746 | Apert like polydactyly syndrome | | | ORPHA | 1 | | 792 | 4801 | 600890 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | HADHB CL E G H | 3032 | 746 | Apert like polydactyly syndrome | | | ORPHA | 1 | | 367 | 4803 | 143450 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | HINT1 CL E G H | 3094 | 324442 | | | | ORPHA | 1 | | 139 | 4912 | 601314 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | ISCU CL E G H | 23479 | 255125 | Myopathy with lactic acidosis, hereditary | 255125 | C1850718 | OMIM | 1 | | 160 | 29882 | 611911 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | KBTBD13 CL E G H | 390594 | 171439 | | | | ORPHA | 1 | | 530 | 37227 | 613727 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | KBTBD13 CL E G H | 390594 | 609273 | Nemaline myopathy 6 | 609273 | C1836472 | OMIM | 1 | | 530 | 37227 | 613727 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | KLHL41 CL E G H | 10324 | 171439 | | | | ORPHA | 1 | | 294 | 16905 | 607701 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | LAMP2 CL E G H | 3920 | 300257 | Danon disease | 300257 | C0878677 | OMIM | 1 | | 807 | 6501 | 309060 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | LDHA CL E G H | 3939 | 612933 | Glycogen storage disease XI | 612933 | C2752022 | OMIM | 1 | | 206 | 6535 | 150000 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MGME1 CL E G H | 92667 | 352447 | | | | ORPHA | 1 | | 157 | 16205 | 615076 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MGME1 CL E G H | 92667 | 615084 | Mitochondrial DNA depletion syndrome 11 | 615084 | C3554462 | OMIM | 1 | | 157 | 16205 | 615076 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MT-TE CL E G H | 4556 | 2596 | Hantavirosis | | | ORPHA | 1 | | | 7479 | 590025 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MT-TK CL E G H | 4566 | 1349 | Chromosome 9, partial monosomy 9p | | C2931695 | ORPHA | 1 | | | 7489 | 590060 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MT-TN CL E G H | 4570 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | | 7493 | 590010 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MT-TS1 CL E G H | 4574 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | | 7497 | 590080 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | MYPN CL E G H | 84665 | 171439 | | | | ORPHA | 1 | | 1485 | 23246 | 608517 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | NDUFS4 CL E G H | 4724 | 252010 | Mitochondrial complex I deficiency | 252010 | C1838979 | OMIM | 1 | | 139 | 7711 | 602694 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | NEB CL E G H | 4703 | 171439 | | | | ORPHA | 1 | | 8530 | 7720 | 161650 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PET100 CL E G H | 100131801 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 76 | 40038 | 614770 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PFKM CL E G H | 5213 | 232800 | Glycogen storage disease, type VII | 232800 | C0017926 | OMIM | 1 | | 678 | 8877 | 610681 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PGAM2 CL E G H | 5224 | 261670 | Glycogen storage disease type X | 261670 | C0268149 | OMIM | 1 | | 174 | 8889 | 612931 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PGK1 CL E G H | 5230 | 300653 | Phosphoglycerate kinase 1 deficiency | 300653 | C1970848 | OMIM | 1 | | 346 | 8896 | 311800 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PGM1 CL E G H | 5236 | 614921 | Congenital disorder of glycosylation type 1t | 614921 | C2752015 | OMIM | 1 | | 413 | 8905 | 171900 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PHKA1 CL E G H | 5255 | 300559 | Glycogen storage disease IXd | 300559 | C1845151 | OMIM | 1 | | 560 | 8925 | 311870 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PNPLA2 CL E G H | 57104 | 610717 | Neutral lipid storage disease with myopathy | 610717 | C1853136 | OMIM | 1 | | 566 | 30802 | 609059 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | POLG CL E G H | 5428 | 254892 | | | | ORPHA | 1 | | 2324 | 9179 | 174763 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | POLG CL E G H | 5428 | 157640 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1 | 157640 | C1834846 | OMIM | 1 | | 2324 | 9179 | 174763 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | POLG CL E G H | 5428 | 258450 | Cerebellar ataxia infantile with progressive external ophthalmoplegia | 258450 | C1850303 | OMIM | 1 | | 2324 | 9179 | 174763 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | POLG2 CL E G H | 11232 | 254892 | | | | ORPHA | 1 | | 357 | 9180 | 604983 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | POLG2 CL E G H | 11232 | 610131 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 4 | 610131 | C1864668 | OMIM | 1 | | 357 | 9180 | 604983 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | PUS1 CL E G H | 80324 | 600462 | Myopathy, lactic acidosis, and sideroblastic anemia 1 | 600462 | C1838103 | OMIM | 1 | | 478 | 15508 | 608109 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RNASEH1 CL E G H | 246243 | 329336 | | | | ORPHA | 1 | | 189 | 18466 | 604123 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RNASEH1 CL E G H | 246243 | 616479 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 | 616479 | C4225312 | OMIM | 1 | | 189 | 18466 | 604123 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RRM2B CL E G H | 50484 | 329336 | | | | ORPHA | 1 | | 354 | 17296 | 604712 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RRM2B CL E G H | 50484 | 254892 | | | | ORPHA | 1 | | 354 | 17296 | 604712 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RRM2B CL E G H | 50484 | 613077 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 5 | 613077 | C2751319 | OMIM | 1 | | 354 | 17296 | 604712 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RSPH4A CL E G H | 345895 | 612649 | Ciliary dyskinesia, primary, 11 | 612649 | C2675229 | OMIM | 1 | | 352 | 21558 | 612647 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | RSPH9 CL E G H | 221421 | 612650 | Ciliary dyskinesia, primary, 12 | 612650 | C2675228 | OMIM | 1 | | 170 | 21057 | 612648 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SCO1 CL E G H | 6341 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 212 | 10603 | 603644 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SDHA CL E G H | 6389 | 252011 | Mitochondrial complex II deficiency | 252011 | C1855008 | OMIM | 1 | | 2503 | 10680 | 600857 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SDHAF1 CL E G H | 644096 | 252011 | Mitochondrial complex II deficiency | 252011 | C1855008 | OMIM | 1 | | 77 | 33867 | 612848 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SDHD CL E G H | 6392 | 252011 | Mitochondrial complex II deficiency | 252011 | C1855008 | OMIM | 1 | | 686 | 10683 | 602690 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SLC18A3 CL E G H | 6572 | 617239 | Myasthenic syndrome, congenital, 21, presynaptic | 617239 | C4310654 | OMIM | 1 | | 305 | 10936 | 600336 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SLC25A32 CL E G H | 81034 | 616839 | Exercise intolerance, riboflavin-responsive | 616839 | C4225187 | OMIM | 1 | | 174 | 29683 | 610815 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SLC25A4 CL E G H | 291 | 254892 | | | | ORPHA | 1 | | 333 | 10990 | 103220 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SLC25A4 CL E G H | 291 | 609283 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 | 609283 | C1836460 | OMIM | 1 | | 333 | 10990 | 103220 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | SLC25A4 CL E G H | 291 | 615418 | Mitochondrial DNA depletion syndrome 12b (cardiomyopathic type), autosomal recessive | 615418 | C3809443 | OMIM | 1 | | 333 | 10990 | 103220 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TACO1 CL E G H | 51204 | 220110 | Hepatic failure, early-onset, and neurologic disorder due to cytochrome C oxidase deficiency | 220110 | C0268237 | OMIM | 1 | | 117 | 24316 | 612958 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TAZ CL E G H | 6901 | 302060 | 3-Methylglutaconic aciduria type 2 | 302060 | C0574083 | OMIM | 1 | | | 11577 | 300394 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TK2 CL E G H | 7084 | 254875 | | | | ORPHA | 1 | | 442 | 11831 | 188250 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TMEM126B CL E G H | 55863 | 618250 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29 | 618250 | | OMIM | 1 | | 116 | 30883 | 615533 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TOP3A CL E G H | 7156 | 618098 | PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5 | 618098 | CN253818 | OMIM | 1 | | 390 | 11992 | 601243 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TPM2 CL E G H | 7169 | 171439 | | | | ORPHA | 1 | | 341 | 12011 | 190990 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TPM3 CL E G H | 7170 | 171439 | | | | ORPHA | 1 | | 343 | 12012 | 191030 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TRMT5 CL E G H | 57570 | 616539 | Combined oxidative phosphorylation deficiency 26 | 616539 | C4225290 | OMIM | 1 | | 220 | 23141 | 611023 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TWNK CL E G H | 56652 | 254892 | | | | ORPHA | 1 | | 450 | 1160 | 606075 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 1 | | 450 | 1160 | 606075 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | YARS2 CL E G H | 51067 | 613561 | Myopathy, lactic acidosis, and sideroblastic anemia 2 | 613561 | C3150802 | OMIM | 1 | | 274 | 24249 | 610957 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | FARSB CL E G H | 10056 | 613658 | Rajab syndrome | 613658 | C3150910 | OMIM | 0 | | 169 | 17800 | 609690 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | GMPPB CL E G H | 29925 | 363623 | | | | ORPHA | 0 | | 364 | 22932 | 615320 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | POLG CL E G H | 5428 | 254886 | | | | ORPHA | 0 | | 2324 | 9179 | 174763 |
HP:0003546 | HP:0003546 | Exercise intolerance | 0 | TK2 CL E G H | 7084 | 254886 | | | | ORPHA | 0 | | 442 | 11831 | 188250 |